Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials

Open access
Cutlip, Donald E., Chhabra, Amit G., Baim, Donald S., Chauhan, Manish S., Marulkar, Sachin, Massaro, Joseph, Bakhai, Ameet, Cohen, David J., Kuntz, Richard E., Ho, Kalon K.L. · 2004 · Circulation

Abstract

Background— In the first year after coronary stent implantation, clinical failures are driven mainly by procedural complications and restenosis, but the subsequent relative contributions of restenosis and disease progression to late failures are less clear. Methods and Results— We observed 1228 patients for 5 years after the implantation of stents as part of pivotal second-generation coronary stent trials. Clinical events of death, myocardial infarction, repeat revascularization, and repeat hospitalization for acute coronary syndrome or congestive heart failure were attributed to the index stented (target) lesion or other distinct sites (either in the target or other coronary vessels) and further classified as procedural, restenosis, or nonrestenosis. During the first year the hazard rate was 18.3% for target-lesion events and 12.4% for events unrelated to the target lesion. After the first year the average annual hazard rate was 1.7% for target-lesion events and 6.3% for nontarget-lesion events. By the fifth year, restenosis events occurred in 20.3% of patients, whereas 30-day procedural complications or later nonrestenosis events occurred in 37.9%, including 11.4% who also experienced a restenosis event, for a combined cumulative event rate of 46.4%. Diabetes mellitus and multivessel disease were independently associated with increased risk for both restenosis and nonrestenosis events. Conclusion— In a low-risk clinical trial population, the clinical outcome beyond 1 year after stenting is determined by a high rate of events related to disease progression in segments other than the stented lesion, which itself remains relatively stable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000140721.27004.4b

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 302

Metadata

Authors
Cutlip, D. E., Chhabra, A. G., Baim, D. S., Chauhan, M. S., Marulkar, S., Massaro, J., Bakhai, A., Cohen, D. J., Kuntz, R. E., & Ho, K. K. L.
Venue
Circulation
Published
2004-09-07
Volume
110
Issue
10
Pages
1226-1230
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2032273096
Cited by
302
References
13
FWCI
18.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials. https://app.cochat.ai/papers/10.1161/01.cir.0000140721.27004.4b
The paper
Cutlip, D. E., Chhabra, A. G., Baim, D. S., Chauhan, M. S., Marulkar, S., Massaro, J., Bakhai, A., Cohen, D. J., Kuntz, R. E., & Ho, K. K. L. (2004). Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials. Circulation. https://doi.org/10.1161/01.cir.0000140721.27004.4b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.